Yanlong Wang
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Naringenin ameliorates postmenopausal osteoporosis by inhibiting BMSC oxidative stress via the PI3K/AKT/NRF2 pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 30, 2026
Acupuncture's Immunomodulatory Effects on Macrophages in Allergic Disorders: A Systematic Review.
Journal: Journal of asthma and allergy
Published: January 10, 2025
Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Journal: Bioengineered
Published: February 21, 2022
MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1.
Journal: Cancer medicine
Published: September 27, 2019
LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Journal: Journal of cellular biochemistry
Published: November 09, 2017
Necrosis of osteosarcoma cells induces the production and release of high-mobility group box 1 protein.
Journal: Experimental and therapeutic medicine
Published: July 24, 2016
Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation.
Journal: International immunopharmacology
Published: October 17, 2014
The tumor suppressor role of PAQR3 in osteosarcoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026